141 related articles for article (PubMed ID: 18704934)
1. Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia.
Kazemi T; Asgarian-Omran H; Hojjat-Farsangi M; Shabani M; Memarian A; Sharifian RA; Razavi SM; Jeddi-Tehrani M; Rabbani H; Shokri F
Int J Cancer; 2008 Nov; 123(9):2113-9. PubMed ID: 18704934
[TBL] [Abstract][Full Text] [Related]
2. Low representation of Fc receptor-like 1-5 molecules in leukemic cells from Iranian patients with acute lymphoblastic leukemia.
Kazemi T; Asgarian-Omran H; Memarian A; Shabani M; Sharifian RA; Vossough P; Ansaripour B; Rabbani H; Shokri F
Cancer Immunol Immunother; 2009 Jun; 58(6):989-96. PubMed ID: 18802695
[TBL] [Abstract][Full Text] [Related]
3. FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.
Li FJ; Ding S; Pan J; Shakhmatov MA; Kashentseva E; Wu J; Li Y; Soong SJ; Chiorazzi N; Davis RS
Blood; 2008 Jul; 112(1):179-87. PubMed ID: 18314442
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the human FCRL1, 2, and 4 gene expressions in patients with rheumatoid arthritis.
Khanzadeh A; Habibagahi Z; Hosseini A; Amirghofran Z
Rheumatol Int; 2016 Aug; 36(8):1149-56. PubMed ID: 27193470
[TBL] [Abstract][Full Text] [Related]
5. FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins.
Du X; Nagata S; Ise T; Stetler-Stevenson M; Pastan I
Blood; 2008 Jan; 111(1):338-43. PubMed ID: 17895404
[TBL] [Abstract][Full Text] [Related]
6. Expression Profile of Human Fc Receptor-Like 1, 2, and 4 Molecules in Peripheral Blood Mononuclear Cells of Patients with Hashimoto's Thyroiditis and Graves' Disease.
Rostamzadeh D; Dabbaghmanesh MH; Shabani M; Hosseini A; Amirghofran Z
Horm Metab Res; 2015 Aug; 47(9):693-8. PubMed ID: 25738996
[TBL] [Abstract][Full Text] [Related]
7. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
[TBL] [Abstract][Full Text] [Related]
8. Expression profile of galectin-1 and galectin-3 molecules in different subtypes of chronic lymphocytic leukemia.
Asgarian-Omran H; Forghani P; Hojjat-Farsangi M; Roohi A; Sharifian RA; Razavi SM; Jeddi-Tehrani M; Rabbani H; Shokri F
Cancer Invest; 2010 Aug; 28(7):717-25. PubMed ID: 20590446
[TBL] [Abstract][Full Text] [Related]
9. 1q23.1 homozygous deletion and downregulation of Fc receptor-like family genes confer poor prognosis in chronic lymphocytic leukemia.
Daniele G; L'Abbate A; Turchiano A; Palumbo O; Carella M; Lo Cunsolo C; Iuzzolino P; Lonoce A; Hernández-Sánchez M; Minoia C; Leone P; Hernandez-Rivas JM; Storlazzi CT
Clin Exp Med; 2019 May; 19(2):261-267. PubMed ID: 30877410
[TBL] [Abstract][Full Text] [Related]
10. Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy.
Daneshmanesh AH; Mikaelsson E; Jeddi-Tehrani M; Bayat AA; Ghods R; Ostadkarampour M; Akhondi M; Lagercrantz S; Larsson C; Osterborg A; Shokri F; Mellstedt H; Rabbani H
Int J Cancer; 2008 Sep; 123(5):1190-5. PubMed ID: 18546292
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
12. Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia.
Li FJ; Kubagawa Y; McCollum MK; Wilson L; Motohashi T; Bertoli LF; Barton JC; Barnes S; Davis RS; Kubagawa H
Blood; 2011 Nov; 118(18):4902-9. PubMed ID: 21908424
[TBL] [Abstract][Full Text] [Related]
13. FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia.
Nückel H; Collins CH; Frey UH; Sellmann L; Dürig J; Siffert W; Dührsen U
Eur J Haematol; 2009 Dec; 83(6):541-9. PubMed ID: 19682311
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia.
Polson AG; Zheng B; Elkins K; Chang W; Du C; Dowd P; Yen L; Tan C; Hongo JA; Koeppen H; Ebens A
Int Immunol; 2006 Sep; 18(9):1363-73. PubMed ID: 16849395
[TBL] [Abstract][Full Text] [Related]
16. Variation in WNT genes expression in different subtypes of chronic lymphocytic leukemia.
Memarian A; Hojjat-Farsangi M; Asgarian-Omran H; Younesi V; Jeddi-Tehrani M; Sharifian RA; Khoshnoodi J; Razavi SM; Rabbani H; Shokri F
Leuk Lymphoma; 2009 Dec; 50(12):2061-70. PubMed ID: 19863181
[TBL] [Abstract][Full Text] [Related]
17. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
[TBL] [Abstract][Full Text] [Related]
18. Expression profile of Fc receptor-like molecules in patients with IgA nephropathy.
Zhong Z; Shi D; Xiao M; Fu D; Feng S; Kong Q; Li J; Li Z
Hum Immunol; 2021 Mar; 82(3):186-192. PubMed ID: 33597097
[TBL] [Abstract][Full Text] [Related]
19. Fc Receptor-Like 1 as a Promising Target for Immunotherapeutic Interventions of B-Cell-Related Disorders.
Yousefi Z; Sharifzadeh S; Yar-Ahmadi V; Andalib A; Eskandari N
Biomark Insights; 2019; 14():1177271919882351. PubMed ID: 31798301
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
